| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9956573 | International Journal of Cardiology | 2005 | 4 Pages |
Abstract
In conclusion, verapamil does not exert any beneficial effect on documented episodes of atrial tachyarrhythmia in patients with brady-tachy syndrome implanted with a DDDR device. Moreover, this drug was ineffective in reducing the number of palpitation episodes reported by the patient.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Giuseppe Boriani, Emanuele Bertaglia, Angelo Carboni, Raoul Latini, Mauro Biffi, Cristian Martignani, Fortunata Sciotto, Angelo Branzi,